Cytori to Present at 2008 BIOCOM Investor Conference on October 27
Cytori Therapeutics, Inc., (NASDAQ:CYTX) will present and provide an audio webcast of its corporate presentation at the 2008 BIOCOM Investor Conference at 1:00 p.m. (Eastern Daylight Time) on Monday, October 27, 2008 at the Hyatt Regency La Jolla in California.
The audio-visual webcast may be accessed under “Events & Webcasts” in the Investor Relations section of the Company’s website, http://www.cytoritx.com. The webcast can be watched live and will be available for replay one hour after the presentation on the company’s website. The webcast will be archived for 90 days.
Cytori’s (NASDAQ:CYTX) goal is to be the global leader in regenerative medicine. The company is dedicated to providing patients with new options for reconstructive surgery, developing treatments for cardiovascular disease, and banking patients’ adult stem and regenerative cells. The Celution(R) 800 System is being introduced in Europe into the reconstructive surgery market while the Celution(R) 900 System is being commercialized globally for cryopreserving a patient’s own stem and regenerative cells. Clinical trials are ongoing in cardiovascular disease and planned for spinal disc degeneration, gastrointestinal disorders and other unmet medical needs. www.cytoritx.com